Literature DB >> 15785005

Variable number of tandem repeat of the 5'-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension.

Noriko Aoi1, Masayoshi Soma, Tomohiro Nakayama, Dolkun Rahmutula, Kotoko Kosuge, Yoichi Izumi, Koichi Matsumoto.   

Abstract

The gene for natriuretic peptides receptor C (NPRC), which is a candidate susceptibility gene for essential hypertension (EH) or obese hypertension, plays a key role in the regulation of plasma levels and biological effects of natriuretic peptides. The aims of the present study were to find new genetic markers in the 5'-flanking region of the NPRC gene and to assess relationships between variants and phenotypes of EH, including EH in obese patients. Using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis, we discovered a novel six-nucleotide repeat polymorphism located 4 base pairs (bp) upstream of the major transcriptional initiation site. We performed association analysis of this variable number of tandem repeat (VNTR) in 242 EH patients and 212 normotensive controls (NT). Although no significant difference in overall frequency of VNTR was found between NT and EH groups, the blood pressure level of EH patients with the 5/6 genotype was significantly higher in obese subjects. This suggests that the VNTR of the 5'-flanking region of the NPRC gene influences blood pressure levels in obesity-associated hypertension.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15785005     DOI: 10.1291/hypres.27.711

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  12 in total

Review 1.  NPR-C: a component of the natriuretic peptide family with implications in human diseases.

Authors:  Speranza Rubattu; Sebastiano Sciarretta; Angelica Morriello; Camilla Calvieri; Allegra Battistoni; Massimo Volpe
Journal:  J Mol Med (Berl)       Date:  2010-06-19       Impact factor: 4.599

Review 2.  Genetic variation in the natriuretic peptide system and heart failure.

Authors:  David E Lanfear
Journal:  Heart Fail Rev       Date:  2008-10-11       Impact factor: 4.214

3.  Inflammation, a link between obesity and cardiovascular disease.

Authors:  Zhaoxia Wang; Tomohiro Nakayama
Journal:  Mediators Inflamm       Date:  2010-08-05       Impact factor: 4.711

4.  Is natriuretic peptide receptor C a new target for hypertension therapeutics?

Authors:  Yanfei Qi; Mohan K Raizada
Journal:  Hypertension       Date:  2014-01-27       Impact factor: 10.190

Review 5.  Arterial Stiffness and Decline in Kidney Function.

Authors:  Sanaz Sedaghat; Francesco U S Mattace-Raso; Ewout J Hoorn; Andre G Uitterlinden; Albert Hofman; M Arfan Ikram; Oscar H Franco; Abbas Dehghan
Journal:  Clin J Am Soc Nephrol       Date:  2015-11-12       Impact factor: 8.237

6.  Recombinant murine fibroblast growth factor 21 ameliorates obesity-related inflammation in monosodium glutamate-induced obesity rats.

Authors:  Wen-Fei Wang; Si-Ming Li; Gui-Ping Ren; Wei Zheng; Yu-Jia Lu; Yin-Hang Yu; Wen-Juan Xu; Tian-He Li; Li-Hong Zhou; Yan Liu; De-Shan Li
Journal:  Endocrine       Date:  2014-10-12       Impact factor: 3.633

Review 7.  C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target.

Authors:  Natalie G Lumsden; Rayomand S Khambata; Adrian J Hobbs
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

Review 8.  Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection.

Authors:  Amanda N Long; Samuel Dagogo-Jack
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-04       Impact factor: 3.738

9.  Impact of natriuretic peptide clearance receptor (NPR3) gene variants on blood pressure in type 2 diabetes.

Authors:  Pierre-Jean Saulnier; Ronan Roussel; Jean Michel Halimi; Jeremie Lebrec; Dured Dardari; Sulyia Maimaitiming; Gérard Guilloteau; Xavier Prugnard; Richard Marechaud; Stephanie Ragot; Michel Marre; Samy Hadjadj
Journal:  Diabetes Care       Date:  2011-04-04       Impact factor: 19.112

10.  Endothelial C-type natriuretic peptide maintains vascular homeostasis.

Authors:  Amie J Moyes; Rayomand S Khambata; Inmaculada Villar; Kristen J Bubb; Reshma S Baliga; Natalie G Lumsden; Fang Xiao; Paul J Gane; Anne-Sophie Rebstock; Roberta J Worthington; Michela I Simone; Filipa Mota; Fernando Rivilla; Susana Vallejo; Concepción Peiró; Carlos F Sánchez Ferrer; Snezana Djordjevic; Mark J Caulfield; Raymond J MacAllister; David L Selwood; Amrita Ahluwalia; Adrian J Hobbs
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.